Total Compensation FY2024
$24.4M
As reported in 2025 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
$1.9M
8% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
$714,332
3% of total
About Robert Bradway
Robert Bradway has served as Amgen's CEO since 2012, overseeing the biotech company's expansion into new therapeutic areas.
Data Source: Compensation figures are sourced from Amgen Inc.'s DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2024 as reported in the Summary Compensation Table.